Curcumin shows promise for osteoarthritis pain with fewer side effects than NSAIDs

An umbrella review examined multiple studies on curcumin formulations for treating osteoarthritis. The analysis looked at how these supplements compared to non-steroidal anti-inflammatory drugs, commonly known as NSAIDs. The review included studies with varying designs and curcumin compositions. Researchers found that curcumin led to significant improvements in pain and joint function or stiffness. These benefits were comparable to the effects seen with NSAIDs. The review also noted that curcumin had a more favorable tolerability profile in the available studies. Safety data were incomplete across the reviews, and serious adverse events were not reported in detail. The studies showed substantial differences in how curcumin was made and taken. Only three studies were rated as high quality by the review standards. Because of these variations and limited data, definitive conclusions about which formulation is best are not possible. Readers should understand that while curcumin shows promise for symptom management, more research is needed to confirm these findings and establish optimal dosing.